Skip to main content
. 2018 Nov;24(11):2098–2102. doi: 10.3201/eid2411.171410

Table 2. Outcomes of SARI patients with and without laboratory-confirmed influenza. Beijing, China, week 40, 2014–week 39, 2016*.

Characteristic All SARI patients, n = 2,212 SARI patients without confirmed influenza, n = 1,759 SARI patients with confirmed influenza, n = 453 p value†
Sex
M 1,298 (58.7) 1,030 (58.6) 268 (59.2) 0.816
F
914 (41.3)
729 (41.4)
185 (40.8)

Age group, y
0–4 973 (44.0) 778 (44.2) 195 (43.1) <0.001
5–14 368 (16.6) 260 (14.8) 108 (23.8)
15–24 40 (1.8) 35 (2.0) 5 (1.1)
25–59 284 (12.8) 235 (13.4) 49 (10.8)
>60
547 (24.7)
451 (25.6)
96 (21.2)

Underlying medical condition
>1‡ 548 (24.8) 450 (25.6) 98 (21.6) 0.083
Pulmonary diseases§ 224 (10.1) 175 (10.0) 49 (10.8) 0.585
Cardiovascular diseases 380 (17.2) 321 (18.3) 59 (13.0) 0.009
Metabolic diseases¶ 71 (3.2) 61 (3.5) 10 (2.2) 0.175
Renal dysfunction 22 (1.0) 19 (1.1) 3 (0.7) 0.424
Hepatic dysfunction 10 (0.5) 10 (0.6) 0 (0.0) 0.108
Tumor 31 (1.4) 27 (1.5) 4 (0.9) 0.292
Immune system diseases
1 (0.1)
1 (0.1)
0 (0.0)
0.612
Received influenza vaccine within 1 y
121 (5.5)
90 (5.1)
31 (6.8)
0.15
Treatment
Antiviral drugs 30 (1.4) 14 (0.8) 16 (3.5) <0.001
Antibacterial drugs 2,171 (98.2) 1,722 (97.9) 449 (99.1) 0.086
Corticosteroids 214 (9.7) 154 (8.8) 60 (13.3) 0.004
Oxygen therapy 589 (26.6) 492 (28.0) 97 (21.4) 0.005
Mechanical ventilation
12 (0.5)
8 (0.5)
4 (0.9)
0.428
Complication 510 (23.1) 415 (23.6) 95 (21.0) 0.237
Pneumonia
389 (17.6)
321 (18.3)
68 (15.0)
0.106
Median length of hospital stay, d (IQR)
8.8 (8.6–9.0)
9.0 (8.7–9.3)
8.0 (7.5–8.4)
<0.001
Admission to ICU
28 (1.3)
20 (1.1)
8 (1.8)
0.286
Died 9 (0.4) 8 (0.5) 1 (0.2) 0.485

*Values are no. (%) unless otherwise indicated. The weeks range from 2014 Sep 29 through 2016 Oct 2. ICU, intensive care unit; IQR, interquartile range; SARI, severe acute respiratory infection. 
†Calculated by χ2 test.
‡Defined as any inpatient stays with admission diagnosis in any of the following diseases, symptoms, or signs: pulmonary disease, cardiovascular disease, chronic metabolic disease, renal dysfunction, hepatic diseases, or tumor.
§Asthma, chronic obstructive pulmonary disease, emphysema, chronic bronchitis.
¶Diabetes, dyslipidemia.